Novartis
The initiative will support the NHS in its recovery as it navigates the COVID-19 pandemic.
The results will not impact the current rollout of a new version of the app, under special FDA guidelines.
It's been quite a year for digital, from Akili's de novo clearance to the downfall of 'digital pill' maker Proteus. MobiHealthNews takes a look back at the highlights.
At a recent online event, Novartis Chief Digital Officer Betrand Bodson gave an update on a digital strategy that began in 2018.
The new expansion is linked to a partnership the digital health company has with Novartis.
The co-packaged product, which will be launched in Europe this year, combines Propeller's sensor tech and Novartis' new medication.
Also: TapestryHealth purchases its telehealth tech vendor; Tech professionals eyeing healthcare and pharma jobs with new interest after COVID-19.
Also: HHS awards $20 million in telehealth access, infrastructure funds; Lumi launches online service.
Alongside the purchase of Amblyotech, the pharma company announced upcoming collaborations with major video game publisher Ubisoft and McGill University.
The industry is better off viewing the the floundering deals between Onduo and Sanofi, Proteus and Otsuka, and Pear and Sandoz as a learning opportunity.